Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Prostaglandins, Leukotrienes and Essential Fatty Acids

• Publication date

  1993-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0952-3278(93)90207-DPMID 7508131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders.

  1991cited by this paper
• Hormonal regulation of cyclic nucleotide phosphodiesterases.

  1991cited by this paper
• Interaction between prostaglandin E1 and nitric oxide (NO).

  1991cited by this paper
• Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets.

  1991cited by this paper
• Biosynthesis and interaction of endothelium-derived vasoactive mediators.

  1991cited by this paper
• Regulatory functions of the vascular endothelium.

  1990cited by this paper
• Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

  1990cited by this paper
• Iloprost and tissue-type plasminogen activator differentially affect platelet aggregation in platelet-rich plasma and in whole blood.

  1990cited by this paper
• Mechanisms of platelet activation and inhibition.

  1990cited by this paper
• Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.

  1990cited by this paper
• Characterization of the l‐arginine: nitric oxide pathway in human platelets

  1990cited by this paper
• An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

  1990cited by this paper
• Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease.

  1990cited by this paper
• Relationship between prostacyclin and nitric oxide in the thrombotic process.

  1990cited by this paper
• Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.

  1988cited by this paper
• Organic Nitrates: Direct Antiplatelet Effects and Synergism with Prostacyclin

  1988cited by this paper
• Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin.

  1988cited by this paper
• Vascular endothelial cells synthesize nitric oxide from L-arginine

  1988cited by this paper
• Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

  1988cited by this paper
• Mediators Produced by the Endothelial Cell

  1988cited by this paper
• EFFECT OF LABETALOL ON HUMAN PLATELET FUNCTION

  1988cited by this paper
• Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.

  1988cited by this paper
• Effects of Iloprost on Platelet Activation In Vitro

  1987cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.

  1987cited by this paper
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

  1987cited by this paper
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

  1987cited by this paper
• The Novel Effect of a New Prostacyclin Analogue ZK36374 on the Aggregation of Human Platelets in Whole Blood

  1983cited by this paper
• Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.

  1982cited by this paper
• Prostacyclin and arterial wall biology.

  1982cited by this paper
• The Interaction of Sodium Nitroprusside with Human Endothelial Cells and Platelets: Nitroprusside and Prostacyclin Synergistically Inhibit Platelet Function

  1982cited by this paper
• Intravenous Infusion of Prostacyclin Sodium in Man: Clinical Effects and Influence on Platelet Adenosine Diphosphate Sensitivity and Adenosine 3′:5′‐Cyclic Monophosphate Levels

  1981cited by this paper
• Possible ozone reductions and UV changes at the Earth's surface

  1980cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

  1977cited by this paper
• Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

  1977cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects

  2007cites this paper
• High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism

  2005cites this paper
• Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes.

  2003cites this paper
• Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation.

  2002cites this paper
• Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase.

  2002cites this paper
• Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function.

  2002cites this paper
• Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.

  2001cites this paper
• L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.

  1999cites this paper
• Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3′ : 5′-cyclic monophosphate and adenosine 3′ : 5′-cyclic monophosphate concentrations

  1999cites this paper
• Therapeutics of nitric oxide modulation.

  1999cites this paper
• Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells

  1998cites this paper
• Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans.

  1998cites this paper
• Insulin Stimulates Nitric Oxide Synthesis in Human Platelets and, Through Nitric Oxide, Increases Platelet Concentrations of Both Guanosine-3′, 5′-Cyclic Monophosphate and Adenosine-3′, 5′-Cyclic Monophosphate

  1997cites this paper
• Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide

  1996cites this paper
• Role of catecholamines in platelet function: pathophysiological and clinical significance

  1996cites this paper
• Nitric oxide inhibits ATP-dependent Ca2+ uptake into platelet membrane vesicles.

  1996cites this paper
• Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects

  1996cites this paper
• The Insulin-Induced Increase of Guanosine-3′,5′-Cyclic Monophosphate in Human Platelets Is Mediated by Nitric Oxide

  1996cites this paper
• GLYCERYL TRINITRATE ENHANCES THE ADENOSINE‐INDUCED INHIBITION OF PLATELET RESPONSES: A MECHANISM POTENTIALLY INVOLVED IN THE IN VIVO ANTI‐AGGREGATING EFFECTS OF ORGANIC NITRATES

  1995cites this paper
• Platelet cAMP and cGMP Phosphodiesterases.

  1995cites this paper
• Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets.

  1994cites this paper